Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress

Go back to Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Tops Q1 EPS by 70c, Revenues Miss

May 7, 2020 5:39 PM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($2.44), $0.70 better than the analyst estimate of ($3.14). Revenue for the quarter came in at $2.29 million versus the consensus estimate of $2.8 million.

I... More